These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33653456)

  • 1. Nanoliposomes@Transcutol for
    Sinico C; Maria Fadda A; Valenti D; Pireddu R; Corrias F; Schlich M; Pitzanti G; Lai F
    J Nanosci Nanotechnol; 2021 May; 21(5):2901-2906. PubMed ID: 33653456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutol
    Pitzanti G; Rosa A; Nieddu M; Valenti D; Pireddu R; Lai F; Cardia MC; Fadda AM; Sinico C
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
    Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
    Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutol containing vesicles for topical delivery of minoxidil.
    Mura S; Manconi M; Valenti D; Sinico C; Vila AO; Fadda AM
    J Drug Target; 2011 Apr; 19(3):189-96. PubMed ID: 20446805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin.
    Manconi M; Sinico C; Caddeo C; Vila AO; Valenti D; Fadda AM
    Int J Pharm; 2011 Jun; 412(1-2):37-46. PubMed ID: 21530626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical optimization of tretinoin-loaded penetration-enhancer vesicles (PEV) for topical delivery.
    Bavarsad N; Akhgari A; Seifmanesh S; Salimi A; Rezaie A
    Daru; 2016 Feb; 24():7. PubMed ID: 26926453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deformable liposomes as enhancer of caffeine penetration through human skin in a Franz diffusion cell test.
    Abd E; Gomes J; Sales CC; Yousef S; Forouz F; Telaprolu KC; Roberts MS; Grice JE; Lopes PS; Leite-Silva VR; Andréo-Filho N
    Int J Cosmet Sci; 2021 Feb; 43(1):1-10. PubMed ID: 32866296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanovesicular carrier-mediated transdermal delivery of tadalafil: i-formulation and physicsochemical characterization.
    Mehanna MM; Motawaa AM; Samaha MW
    Drug Dev Ind Pharm; 2015 May; 41(5):714-21. PubMed ID: 24669976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
    Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
    Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close-packed vesicles for diclofenac skin delivery and fibroblast targeting.
    Manca ML; Manconi M; Falchi AM; Castangia I; Valenti D; Lampis S; Fadda AM
    Colloids Surf B Biointerfaces; 2013 Nov; 111():609-17. PubMed ID: 23907049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy.
    Abdel-Hafez SM; Hathout RM; Sammour OA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():63-72. PubMed ID: 29626721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery?
    Caddeo C; Manconi M; Sinico C; Valenti D; Celia C; Monduzzi M; Fadda AM
    Curr Drug Targets; 2015; 16(13):1438-47. PubMed ID: 25090983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibilities of the microemulsion use as indomethacin solubilizer and its effect on
    Špaglová M; Čuchorová M; Šimunková V; Matúšová D; Čierna M; Starýchová L; Bauerová K
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1468-1476. PubMed ID: 32715801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Microdialysis for Dynamic Monitoring of the Effectiveness of Nano-liposomes as Vehicles for Topical Psoralen Application.
    Zhang H; Zhang K; Li Z; Zhao J; Zhang Y; Feng N
    Biol Pharm Bull; 2017; 40(11):1996-2000. PubMed ID: 29093350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Penetration and Permeation Properties of Transcutol®-Neat or Diluted Mixtures.
    Osborne DW; Musakhanian J
    AAPS PharmSciTech; 2018 Nov; 19(8):3512-3533. PubMed ID: 30421383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
    Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
    Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment.
    Garg BJ; Garg NK; Beg S; Singh B; Katare OP
    J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
    Lowe NJ; Weingarten D; Bourget T; Moy LS
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.